Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- ZTS
- Price
- 124.40
- Stock movement down
- -0.68 (-0.54%)
- Company name
- Zoetis Inc
- Exchange
- (NYSE ,
- Currency
- USD )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 52.51B
- Ent value
- 62.34B
- Price/Sales
- 5.55
- Price/Book
- 15.76
- Div yield
- 1.70%
- Div growth
- 13.40%
- Growth years
- 9
- FCF payout
- 38.94%
- Trailing P/E
- 19.65
- Forward P/E
- 16.42
- PEG
- 2.31
- EPS growth
- 11.99%
- 1 year return (CAGR)
- -25.74%
- 3 year return (CAGR)
- -7.96%
- 5 year return (CAGR)
- -5.02%
- 10 year return (CAGR)
- 11.14%
Last updated: 2026-03-11
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
Dividend yield - 5y
Loading...
Dividend yield data
| Dividend per share | 2.12 |
| Dividend yield | 1.70% |
| Payout frequency | Quarterly |
| Maximum yield | 1.73% |
| Average yield | 0.91% |
| Minimum yield | 0.47% |
| Discount to avg yield | 46.58% |
| Upside potential | 87.20% |
| Yield as % of max yield | 98.63% |
Yield distribution (inverse percentile) - 5y
Loading...
Yield distribution data
| Dividend yield | 1.70% |
| Current yield distribution | 0.32% |
| Yield at 100% (Min) | 0.47% |
| Yield at 90% | 0.57% |
| Yield at 80% | 0.65% |
| Yield at 50% (Median) | 0.88% |
| Yield at 20% | 1.06% |
| Yield at 10% | 1.31% |
| Yield at 0% (Max) | 1.73% |
Dividend per share
Loading...
Dividend per share data
| Years of growth | 9 years |
| CCC status | Dividend Challenger |
| Dividend per share | 2.12 |
| Payout frequency | Quarterly |
| Ex-div date | 20 Apr 2026 |
| EPS (TTM) | 6.09 |
| EPS (1y forward) | 7.58 |
| EPS growth (5y) | 11.99% |
| EPS growth (5y forward) | 8.51% |
Dividend growth
Loading...
Please create a free account or log in to access this chart
Dividend growth data
| ZTS | S&P500 | |
| DGR MR | 6.00% | -13.74% |
| DGR TTM | 14.70% | 6.60% |
| DGR 3 years | 4.89% | 7.31% |
| DGR 5 years | 13.40% | 4.69% |
| DGR 10 years | 16.28% | 6.30% |
| DGR 15 years | - | 8.16% |
| Time since last change announced | 91 days |
| EPS growth (5y) | 11.99% |
| EPS growth (5y forward) | 8.51% |
Payout ratio
Loading...
Please create a free account or log in to access this chart
Payout ratio data
| EPS coverage | FCF coverage | |
| TTM | 33.26% | 38.94% |
| Average | 6.23% | 7.13% |
| Forward | 27.98% | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 19.65 |
| Price to OCF | 18.08 |
| Price to FCF | 23.00 |
| Price to EBITDA | 12.85 |
| EV to EBITDA | 15.25 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 5.55 |
| Price to Book | 15.76 |
| EV to Sales | 6.58 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 422.13M |
| EPS (TTM) | 6.09 |
| FCF per share (TTM) | 5.21 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 9.47B |
| Gross profit (TTM) | 6.67B |
| Operating income (TTM) | 3.60B |
| Net income (TTM) | 2.67B |
| EPS (TTM) | 6.09 |
| EPS (1y forward) | 7.58 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 70.49% |
| Operating margin (TTM) | 38.00% |
| Profit margin (TTM) | 28.23% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 2.31B |
| Net receivables | 1.59B |
| Total current assets | 6.77B |
| Goodwill | 2.77B |
| Intangible assets | 998.00M |
| Property, plant and equipment | 6.89B |
| Total assets | 15.47B |
| Accounts payable | 487.00M |
| Short/Current long term debt | 9.49B |
| Total current liabilities | 2.23B |
| Total liabilities | 12.14B |
| Shareholder's equity | 3.33B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 2.90B |
| Capital expenditures (TTM) | 621.00M |
| Free cash flow (TTM) | 2.28B |
| Dividends paid (TTM) | 889.00M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 80.25% |
| Return on Assets | 17.28% |
| Return on Invested Capital | 21.51% |
| Cash Return on Invested Capital | 18.37% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 124.27 |
| Daily high | 126.47 |
| Daily low | 123.73 |
| Daily Volume | 4.72M |
| All-time high | 247.03 |
| 1y analyst estimate | 151.00 |
| Beta | 0.95 |
| EPS (TTM) | 6.09 |
| Dividend per share | 2.12 |
| Ex-div date | 20 Apr 2026 |
| Next earnings date | 30 Apr 2026 |
Downside potential
Loading...
Downside potential data
| ZTS | S&P500 | |
| Current price drop from All-time high | -49.64% | -0.89% |
| Highest price drop | -53.14% | -56.47% |
| Date of highest drop | 9 Dec 2025 | 9 Mar 2009 |
| Avg drop from high | -14.21% | -10.84% |
| Avg time to new high | 13 days | 12 days |
| Max time to new high | 1020 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
52.51B
Marketcap category
Large-cap
Description
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.
Employees
14500
Website
Investor relations
SEC filings
CEO
Kristin Peck
Country
USA
City
Parsippany
Stock type
Common stock
CCC status
Dividend Challenger
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page